Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.4 USD | +0.00% | -0.55% | -22.13% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.13% | 18.9B | |
+42.20% | 50.93B | |
-0.46% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.51% | 26.02B | |
+7.56% | 13.21B | |
+24.05% | 12.17B | |
+30.19% | 12.16B | |
-6.24% | 11.42B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals' Q1 Non-GAAP Net Loss Narrows as Revenue Increases; 2024 Outlook Affirmed